169 related articles for article (PubMed ID: 17182591)
1. IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome.
Keane MP; Gomperts BN; Weigt S; Xue YY; Burdick MD; Nakamura H; Zisman DA; Ardehali A; Saggar R; Lynch JP; Hogaboam C; Kunkel SL; Lukacs NW; Ross DJ; Grusby MJ; Strieter RM; Belperio JA
J Immunol; 2007 Jan; 178(1):511-9. PubMed ID: 17182591
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients.
Belperio JA; DiGiovine B; Keane MP; Burdick MD; Ying Xue Y; Ross DJ; Lynch JP; Kunkel SL; Strieter RM
Transplantation; 2002 Feb; 73(4):591-9. PubMed ID: 11889437
[TBL] [Abstract][Full Text] [Related]
3. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
[TBL] [Abstract][Full Text] [Related]
4. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
[TBL] [Abstract][Full Text] [Related]
6. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Berlin A; Ross DJ; Kunkel SL; Charo IF; Strieter RM
J Clin Invest; 2001 Aug; 108(4):547-56. PubMed ID: 11518728
[TBL] [Abstract][Full Text] [Related]
7. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group.
Elssner A; Jaumann F; Dobmann S; Behr J; Schwaiblmair M; Reichenspurner H; Fürst H; Briegel J; Vogelmeier C
Transplantation; 2000 Jul; 70(2):362-7. PubMed ID: 10933164
[TBL] [Abstract][Full Text] [Related]
9. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
[TBL] [Abstract][Full Text] [Related]
10. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.
Takenaka M; Subramanian V; Tiriveedhi V; Phelan D; Hachem R; Trulock E; Gelman AE; Patterson GA; Hoshinaga K; Mohanakumar T
J Heart Lung Transplant; 2012 Nov; 31(11):1214-22. PubMed ID: 22980951
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation.
Saini D; Angaswamy N; Tiriveedhi V; Fukami N; Ramachandran S; Hachem R; Trulock E; Meyers B; Patterson A; Mohanakumar T
J Heart Lung Transplant; 2010 Dec; 29(12):1330-6. PubMed ID: 20691611
[TBL] [Abstract][Full Text] [Related]
12. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.
Hardison MT; Galin FS; Calderon CE; Djekic UV; Parker SB; Wille KM; Jackson PL; Oster RA; Young KR; Blalock JE; Gaggar A
J Immunol; 2009 Apr; 182(7):4423-31. PubMed ID: 19299743
[TBL] [Abstract][Full Text] [Related]
13. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
[TBL] [Abstract][Full Text] [Related]
14. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
Jaramillo A; Fernández FG; Kuo EY; Trulock EP; Patterson GA; Mohanakumar T
Pediatr Transplant; 2005 Feb; 9(1):84-93. PubMed ID: 15667618
[TBL] [Abstract][Full Text] [Related]
15. A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.
Tiriveedhi V; Angaswamy N; Brand D; Weber J; Gelman AG; Hachem R; Trulock EP; Meyers B; Patterson G; Mohanakumar T
Clin Exp Immunol; 2012 Jan; 167(1):158-68. PubMed ID: 22132895
[TBL] [Abstract][Full Text] [Related]
16. Role of defensins in the pathogenesis of chronic lung allograft rejection.
Tiriveedhi V; Banan B; Deepti S; Nataraju A; Hachem R; Trulock E; Alexander PG; Thalachallour M
Hum Immunol; 2014 Apr; 75(4):370-7. PubMed ID: 24380698
[TBL] [Abstract][Full Text] [Related]
17. IL-16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis.
Laan M; Lindén A; Riise GC
Clin Exp Immunol; 2003 Aug; 133(2):290-6. PubMed ID: 12869037
[TBL] [Abstract][Full Text] [Related]
18. Human and murine obliterative bronchiolitis in transplant.
McDyer JF
Proc Am Thorac Soc; 2007 Jan; 4(1):37-43. PubMed ID: 17202290
[TBL] [Abstract][Full Text] [Related]
19. Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Gomperts B; Xue YY; Hong K; Mestas J; Ardehali A; Mehrad B; Saggar R; Lynch JP; Ross DJ; Strieter RM
J Clin Invest; 2005 May; 115(5):1150-62. PubMed ID: 15864347
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
